Hercules Capital, Inc. Q3 FY2026 earnings call

• Platform Growth & Scale: Hercules manages approximately $6.5 billion in assets, a 17.7% year-over-year increase. The RIA subsidiary surpassed $2.3 billion in investable capital, supported by new commitments from sophisticated institutional investors.
• Originations Record: For the first three quarters of 2026, the firm achieved record originations of $3.44 billion (up 20% YoY) and record fundings of $1.93 billion (up 9.9% YoY). Q3 saw $701 million in new commitments and over $572 million in gross fundings.
• Credit Discipline & Quality: The weighted average internal credit rating improved to 2.12 (lower is better) from 2.17 in Q2. Grade 1 and 2 credits increased to 68.6%. Non-accrual loans remained stable at two companies, totaling approximately $18.8 million in cost (0.4% of portfolio).
• Portfolio Composition: The debt portfolio is 98% floating rate with floors. Approximately 60% of prime base loans are at their contractual floor due to recent Fed rate increases. 89% of the portfolio consists of first-lien exposures.
• Prepayment Activity: Early loan repayments in Q3 were $148.3 million, below guidance but driven by lower unscheduled activity compared to Q2's record $572.1 million. Year-to-date prepayments exceed $946 million.
• Venture Capital Ecosystem: VC investment activity reached unprecedented levels, with $515.8 billion deployed in the first three quarters of 2026. AI-related deals captured 83% of deal value. Portfolio companies raised $11.3 billion in new capital year-to-date.
• Shareholder Returns: Q3 NII covered the base distribution by 118%, marking the 25th consecutive quarter of supplemental distributions. Undistributed earnings spillover was $167.8 million.

The transcript does not provide a breakdown of financial performance by specific product segment (e.g., BDC vs. Private Credit) in terms of absolute revenue contribution percentages or distinct operating income lines for each. However, it highlights that the total investment portfolio is managed across two primary verticals: Life Sciences and Technology. As of Q3 2026, these two sectors each comprised approximately 50% of the total assets under management ($6.5 billion). The firm reported Total Investment Income of $140.1 million and Net Investment Income (NII) of $87.3 million for the quarter. Additionally, the wholly-owned Registered Investment Advisor (RIA), Hercules Advisor LLC, contributed $6.8 million to NII, representing an 11% year-over-year increase.

• Core Yield: Management expects Q4 core yield to be in the range of 11.8% to 12.0%, maintaining confidence that yields have stabilized after recent compression.
• Prepayments: Expects Q4 prepayment activity to normalize to a range of $200 million to $300 million, up from the slower Q3 pace, which should boost Q4 investment income.
• Expenses: Gross SG&A expenses for Q4 are expected to be between $27.5 million and $28.5 million. RIA expense allocation is estimated at approximately $4.5 million.
• Dividends: Expects quarterly dividends from the RIA to Hercules Capital to be approximately $2.0 million to $2.5 million per quarter.
• Interest Expense: Anticipates an increase in interest expense for Q4 due to recent note issuances and higher borrowing costs.
• Outlook: Maintains an expectation of strong originations in Q4, likely back-end weighted, with 2026 on pace to set new records for commitments and fundings.

• Market Volatility & M&A Uncertainty: Management notes that M&A valuation and process timing remain less certain in certain parts of the market, requiring enhanced monitoring of exit activities.
• Capital Cost Environment: Higher cost of capital makes raising debt more difficult and complex, potentially impacting origination efficiency and pricing discipline.
• Competitive Pressure: Some lenders remain aggressive in deal structure and pricing; while Hercules remains disciplined, there is a risk of margin compression if competitive dynamics shift unfavorably.
• European Turmoil: While currently having minimal impact (as 90%+ of business is US-focused), geopolitical turmoil in Europe is being monitored closely as it could affect international markets where Hercules has a small footprint.
• Equity Depreciation: The portfolio experienced net unrealized depreciation on publicly and privately held equity and investment funds ($13.1 million in Q3), reflecting broader market volatility.

Q: Analyst asked about drivers of headwind on core yields and if further compression is expected.

A: Management confirmed Q4 core yield guidance of 11.8%-12.0%, expressing high confidence that yields have stabilized. They do not expect further material degradation, citing pipeline strength and consistent prepayment economics despite competitive pressures seen over the last 18-24 months.

Q: Analyst asked about Hercules' strategic positioning in the tech sector, specifically regarding AI.

A: Management clarified they avoid pure-play AI or GPU financing. Instead, they invest in sectors driving AI adoption (power, energy, networking) and benefiting from AI capabilities (defense tech, space tech). This strategy aims to capture value from infrastructure and enablement rather than direct speculative AI plays.

Q: Analyst asked about credit quality outlook and forward indicators.

A: Management stated credit outlook remains stable with 100% of accrual-status borrowers current on payments. Key metrics like LTV and funded debt ratios are consistent with prior quarters. No slowdown in capital raising was observed among portfolio companies, suggesting resilience despite market volatility.

Q: Analyst asked why ROEs might be near a trough given rising rates.

A: Management indicated that ROEs have likely reached a floor. They expect ROEs to improve in Q4 due to a rebound in prepayment activity and normalization of non-core income, offsetting the impact of higher interest expenses from refinancing.

Q: Analyst asked about the conversion rate of Letters of Intent (LOIs) into realized exits.

A: Management noted that historically, the majority of companies under LOI proceed to closing transactions. However, timing is uncertain due to regulatory approvals (HSR) and definitive documentation processes, which can take six to nine months. Five companies are currently under LOI.